Donor Peripheral Blood Stem Cell Infusion and Apoptosis in Lymphocytes Induces Immunological Tolerance of Kidney Allografts in Rhesus Monkeys
Donor Peripheral Blood Stem Cell Infusion and Apoptosis in Lymphocytes Induces Immunological Tolerance of Kidney Allografts in Rhesus Monkeys
批准号:
13470245
负责人:
KIMIKAWA Masaaki
金额:
$8.9万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002
中文摘要
点击翻译按钮获取中文摘要
英文摘要
(Background) We previously demonstrated that a nonmyeloablative, T-cell depleting preparative regimen including whole-body irradiation, thymic irradiation and donor bone marrow infusion induced mixed chimerism and allograft tolerance. Although tolerance has been successfully induced in the majority of recipients treated with this approach, broad clinical application requires simplifying the therapeutic regimen.(Methods) Male rhesus monkeys weighing 4-7 kg were used. T-cell depletion was planned using a combination of cyclophosphamide (CY) and the novel agent, FTY720 without irradiation. A second modification was allotransplantation of granulocyte-colony-stimulating factor (G-CSF)-mobilized peripheral blood stem cells (PBSCs), which has been increasingly used clinically as an alternative to allogeneic bone marrow transplantation.(Results) In 3 of 5 recipients in full protocol, renal function remained stable with no evidence of rejection more than 300 days after discontinuing immunosuppressive therapy. Donor-specific hyporesponsiveness was confirmed by sequential in vitro mixed lymphocyte reactions as well as skin transplantation from the original kidney donor in 1 recipient. The donor skin was accepted, while third party skin was rejected.(Conclusions) The mechanisms involved in the long-term immunosuppression-free allograft survival observed here remain to be elucidated. Nevertheless, these encouraging preliminary observations suggest that this approach to tolerance induction is particularly applicable to clinical protocols because of the non-toxic, relatively uncomplicated conditioning regimen required.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
背根神经节中Mrgprd通过一种特异性lncRNA调控阿片类药物耐受的外周机制研究
-
批准号:82371224
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:马柯
-
依托单位:
CD27-CD28-CD8+T细胞调控儿童肝脏移植免疫耐受形成的作用和机制
-
批准号:82371791
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:刘永波
-
依托单位:
Consequences of MALT1 mutation for B cell tolerance
-
批准号:32100719
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:James Qun Wang
-
依托单位:
肠上皮内γδT细胞诱导抗原特异性Treg的体内机制及其对肾移植慢性排斥的抑制作用研究
-
批准号:81170693
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:黄赤兵
-
依托单位:
对Rad18和Rad5的结构和功能研究
-
批准号:31070653
-
项目类别:面上项目
-
资助金额:8.0万元
-
批准年份:2010
-
负责人:向嵩
-
依托单位:
红树对重金属的定位累积及耦合微观分析与耐受策略研究
-
批准号:30970527
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2009
-
负责人:严重玲
-
依托单位:
骨髓间充质干细胞向肝脏星状细胞定向分化的构建及其在诱导同种异体胰岛细胞移植免疫耐受中的作用
-
批准号:30872484
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2008
-
负责人:尹震宇
-
依托单位:
口服MHC肽诱导的受体Treg源性exosome干预肾移植排斥反应的机制研究
-
批准号:30872580
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2008
-
负责人:黄赤兵
-
依托单位:
蛋鸡啄羽相残行为的研究:基于社会性气味识别的控制对策
-
批准号:30770289
-
项目类别:面上项目
-
资助金额:8.0万元
-
批准年份:2007
-
负责人:赵亚军
-
依托单位:
ICOS-Fc诱导特异性移植免疫耐受的实验研究
-
批准号:30371400
-
项目类别:面上项目
-
资助金额:20.0万元
-
批准年份:2003
-
负责人:管文贤
-
依托单位: